DexCom Stock-Based Compensation 2010-2025 | DXCM
DexCom annual/quarterly stock-based compensation history and growth rate from 2010 to 2025. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
- DexCom stock-based compensation for the quarter ending March 31, 2025 was $0.034B, a 12.31% decline year-over-year.
- DexCom stock-based compensation for the twelve months ending March 31, 2025 was $0.415B, a 9.72% increase year-over-year.
- DexCom annual stock-based compensation for 2024 was $0.17B, a 13% increase from 2023.
- DexCom annual stock-based compensation for 2023 was $0.151B, a 19.21% increase from 2022.
- DexCom annual stock-based compensation for 2022 was $0.127B, a 11.55% increase from 2021.
| DexCom Annual Stock-Based Compensation (Millions of US $) |
|
|---|---|
| 2024 | $170 |
| 2023 | $151 |
| 2022 | $127 |
| 2021 | $113 |
| 2020 | $119 |
| 2019 | $103 |
| 2018 | $102 |
| 2017 | $106 |
| 2016 | $111 |
| 2015 | $83 |
| 2014 | $50 |
| 2013 | $25 |
| 2012 | $18 |
| 2011 | $14 |
| 2010 | $9 |
| 2009 | $8 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $32.772B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $193.761B | 84.87 |
| Thermo Fisher Scientific (TMO) | United States | $161.477B | 19.53 |
| Edwards Lifesciences (EW) | United States | $45.180B | 29.62 |
| Alcon (ALC) | Switzerland | $44.047B | 29.77 |
| IDEXX Laboratories (IDXX) | United States | $43.646B | 50.16 |
| IQVIA Holdings (IQV) | United States | $28.484B | 15.95 |
| Mettler-Toledo (MTD) | United States | $25.057B | 29.80 |
| STERIS (STE) | Ireland | $23.437B | 25.81 |
| Waters (WAT) | United States | $20.942B | 29.55 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.918B | 0.00 |
| Hologic (HOLX) | United States | $14.552B | 15.81 |
| Sysmex ADR (SSMXY) | Japan | $10.948B | 31.06 |
| Penumbra (PEN) | United States | $9.671B | 75.91 |
| Masimo (MASI) | United States | $9.290B | 34.27 |
| Globus Medical (GMED) | United States | $8.200B | 19.54 |
| Glaukos (GKOS) | United States | $5.921B | 0.00 |
| Teleflex (TFX) | United States | $5.373B | 8.87 |
| TransMedics (TMDX) | United States | $4.319B | 93.89 |
| Integer Holdings (ITGR) | United States | $4.229B | 22.16 |
| PROCEPT BioRobotics (PRCT) | United States | $3.219B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.513B | 14.96 |
| Veracyte (VCYT) | United States | $2.160B | 30.31 |
| Nihon Kohden (NHNKY) | Japan | $2.019B | 23.16 |
| Elekta AB (EKTAY) | Sweden | $1.983B | 17.83 |
| Alphatec Holdings (ATEC) | United States | $1.602B | 0.00 |
| Artivion (AORT) | United States | $1.317B | 123.40 |
| Tandem Diabetes Care (TNDM) | United States | $1.138B | 0.00 |
| OPKO Health (OPK) | United States | $1.063B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.051B | 5.59 |
| Pulse Biosciences (PLSE) | United States | $1.031B | 0.00 |
| SiBone (SIBN) | United States | $0.785B | 0.00 |
| IRadimed (IRMD) | United States | $0.782B | 39.70 |
| Beta Bionics (BBNX) | United States | $0.613B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 8.91 |
| Mesa Laboratories (MLAB) | United States | $0.549B | 12.87 |
| OrthoPediatrics (KIDS) | United States | $0.538B | 0.00 |
| RxSight (RXST) | United States | $0.534B | 0.00 |
| AxoGen (AXGN) | United States | $0.504B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.447B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.441B | 11.73 |
| Delcath Systems (DCTH) | United States | $0.436B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.433B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.383B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.381B | 0.00 |
| NeuroPace (NPCE) | United States | $0.342B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.316B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.269B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.263B | 0.00 |
| 908 Devices (MASS) | United States | $0.237B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.236B | 14.27 |
| Neuronetics (STIM) | United States | $0.225B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.215B | 0.00 |
| Inogen (INGN) | United States | $0.200B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.172B | 0.00 |
| CVRx (CVRX) | United States | $0.168B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.155B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Accuray (ARAY) | United States | $0.143B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.134B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.114B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.108B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 47.00 |
| EnVVeno Medical (NVNO) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | United States | $0.068B | 0.00 |
| Spectral AI (MDAI) | United States | $0.064B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.059B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.026B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.18 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |